BioHeart, Inc. (OTC:BHRT) Shoots Up 27%
Seite 2 von 9 Neuester Beitrag: 24.04.21 23:08 | ||||
Eröffnet am: | 14.02.12 17:46 | von: Balu4u | Anzahl Beiträge: | 207 |
Neuester Beitrag: | 24.04.21 23:08 | von: Monikawjdha | Leser gesamt: | 13.282 |
Forum: | Hot-Stocks | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 | 4 | 5 | 6 | 7 | 8 | 9 9 > |
Meins war ganz gut, bis ich gestern Schweinshaxe im tiefsten Odenwald gegessen hab ;-)))
Ich bin sehr gespannt was morgen BHRT passiert bzw. kommende Woche
Dürfte ein Startschuß für mehr sein !!
Uns allen hier einen POSITIVEN Wochenstart und viele schöne Tage mit einer nach Norden laufenden BHRT :-))
Sieht aus laut der News, als ob nun das Geld vorhanden wäre !!
SUNRISE, FL -- (Marketwire) -- 03/21/13 -- Bioheart, Inc. (BHRT.OB) (OTCQB: BHRT) has announced that it has secured the necessary funding for the ANGEL trial. This trial will initiate in Mexico at the Hospital Angeles with the Regenerative Medicine Institute (RMI). The phase one trial will test the safety and efficacy of LipiCell" (adipose derived stem cells) in congestive heart failure patients. The first cohort of five patients will be completed and analyzed to help establish a safety profile and preliminary efficacy.
"The facilities at Hospital Angeles and RMI are top notch and we are excited to move the ANGEL trial forward. We anticipate quick enrollment with follow up time points at 3, 6 and 12 months," said Kristin Comella, Chief Science Officer of Bioheart.
Bioheart's cell therapy products address an unmet need in the cardiac market by providing true regenerative medicine where the MyoCell® product line may regenerate muscle in areas of scar tissue and the LipiCell® product may help reduce inflammation and promote the growth of new blood vessels. Bioheart intends to complete a portion of its clinical trials in Mexico to help reduce costs and accelerate the opportunities for commercialization outside the US.
Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the Company's President/CEO has received multiple accolades and honors from both national and international assemblages.
This past Saturday Mr. Tomas attended the 12th Annual Torch Awards at Florida International University (FIU). He was bestowed FIU's highest honor; the 2013 Torch Award for lifetime business, community leadership and civic involvement. https://fiualumni.com/torch2013/
He was also nominated for the 2013 Ernst & Young Entrepreneur of the Year award. The award is considered the world's most prominent business award for entrepreneurs. http://www.ey.com/US/en/About-us/Entrepreneurship/...neur-Of-The-Year
This June Mr. Tomas will be presented the 2013 Father of the Year award by the American Diabetes Association (ADA). Each year the ADA recognizes men from the U.S.A. for the outstanding strength, commitment and love they exhibit as fathers. http://main.diabetes.org/site/...d&loc=Miami&father=MikeTomas
"I am sincerely honored to be recognized by these exceptional organizations. I endeavor to make a positive difference in the lives of others and to push forward on opportunities," said Mr. Tomas.
In the past year, Mike Tomas was inducted into the Miami Dade College Hall of Fame and welcomed into the World Assembly and Council (WACE) Hall of Fame.
Dr. William P. Murphy Jr., Chairman of the Board commented, "Bioheart is fortunate to have someone of Mike's caliber leading our company. His business acumen has been proven time and again throughout his career. He has led his many business ventures to success and I feel confident that Bioheart will be no exception."
Quelle Marketwire via CMTX - 1 hr 9 mins ago